Search
Now showing items 1-2 of 2
CD4+ Cell Response to Anti-Retroviral Therapy (ARTS) In Routine Clinical Care Over One Oear Oeriod in a Cohort of HAART Naive, HIV Positive Kenyan Patients
(University of Nairobi, 2014)
Background: Untreated HIV/AIDS leads to severe immune depletion with opportunistic
infections and other co-morbidities. Highly active anti-retroviral ...
Morbidity and CD4+ Cell Counts at Initial Presentation of a Cohort of HAART-Naive, HIV Positive Kenyan Patients: Implications to Initiating HAART
(University of Nairobi, 2014)
Background: Sub-Saharan Africa with under 10% of the worldfs total population accounts for 60-70% of all HIV/AIDS cases. While these patients require HAART to manage the disease, HAART is not universally available. Majority ...